Introduction chorionic gonadotrophin (HCG) (Chorulon; Intervet). The females
During the past decade, in-vitro fertilization (IVF) and related were then mated to F 1 males of the same strain; the day after only techniques have become reasonably efficient treatments for females with a vaginal plug were killed to collect zygotes from the infertile patients. The number of replaced embryos has been ampoules. The total mouse litters were randomly distributed to the reduced from four to two (Devreker et al., 1999) , and since different experimental groups. The zygotes were placed in culture the introduction of sequential media (Fitzgerald and Di Mattina, 18-20 h after HCG in Earle's modified balanced salt solution (mEBSS) 1992) there has been a move towards the transfer of a (Van den Bergh et al., 1996) supplemented with 0.5% bovine serum single blastocyst. The number of supernumerary embryos is albumin (BSA) fraction V (A 6507; Sigma, St Louis, MO, USA) in continuously increasing, and thus the need for highly efficient 300 µl drops under mineral oil (M8410; Sigma), at 37°C in a cryopreservation techniques is becoming urgent. Because of humidified atmosphere of 5% CO 2 and 5% O 2 . Embryos were randomly allocated to the control, toxicity or frozen groups.
ethical implications concerning human experimentation, pre-Solutions Freezing and thawing solutions were prepared in modified HEPES buffered EBSS (mHEBSS) supplemented with 0.5% BSA, with and without sucrose (S1888; Sigma). The cryoprotectants were 1.5 mol/l ETG (E9129; Sigma), 1.5 mol/l PROH (P6209; Sigma) and 1.5 mol/l glycerol (G5516; Sigma). Three equilibration solutions were used in three different equilibration steps for the freezing procedure with each cryoprotectant. Equilibration solutions were: 0.75 and 1.5 mol/l PROH and 1.5 mol/l PROH ϩ 0.1 mol/l sucrose; 0.75 and 1.5 mol/l ETG and 1.5 mol/l ETG ϩ 0.1 mol/ l sucrose; 0.75 and 1.5 mol/l glycerol and 1.5 mol/l glycerol ϩ 0.1 mol/l sucrose. Three equilibration solutions were also used in three different steps for the thawing procedure with each cryoprotectant. The equilibration solutions were: 1 mol/l PROH ϩ Figure 1 . Van t'Hoff curve for mouse zygotes exposed to 1.5 mol/l 0.2 mol/l sucrose, 0.5 mol/l PROH ϩ 0.2 mol/l sucrose and 0.2 ethylene glycol (ETG). mol/l sucrose; 1 mol/l ETG ϩ 0.2 mol/l sucrose, 0.5 mol/l ETG ϩ 0.2 mol/l sucrose and 0.2 mol/l sucrose; 1 mol/l glycerol ϩ control group that was placed in culture without freezing. Embryos 0.2 mol/l sucrose, 0.5 mol/l glycerol ϩ 0.2 mol/l sucrose and were frozen at three stages: (i) Pronuclear, with ETG and PROH; the 0.2 mol/l sucrose.
survival rate (SR), CR and EBP were measured after thawing, after 24 h and after 120 h respectively. (ii) 4-cell, with ETG and PROH.
Van t'Hoff curve
The SR was measured after thawing (only embryos with at least 50% The osmolar properties of ETG were evaluated by exposing the of intact blastomeres were considered to have survived). The EBP zygotes to 1.5 mol/l ETG, corresponding to an osmolality of 2600 was evaluated after a further 72 h of culture. (iii) Blastocysts, with mOsm, at room temperature and measuring, by video recording, their ETG and glycerol. of the zygotes was observed within the first 2 min, and a Freezing-thawing procedure further 3 min were necessary for the cells to be restored
The same freezing-thawing procedure was used for the three cryoproalmost to their initial volume. Following this observation, a tectants. The embryos were exposed to 0.75 mol/l cryoprotectant for preliminary step of exposure of embryos to 0.75 mol/l ETG 10 min, then to 1.5 mol/l cryoprotectant for 10 min, and finally to was added (1400 mOsm). This step was introduced also for the solution containing the cryoprotectant with sucrose, again for PROH and glycerol to compare the cryoprotective properties 10 min. All passages were made at room temperature. During this on the embryos of the three cryoprotectants under the same last period of equilibration, the embryos were loaded in 0.25 ml conditions. Results of the toxicity test for ETG are shown in Figure 2 . In UK) was used for freezing, and the embryos were cooled as follows: from 22°C to -7°C at -2°C/min, at -7°C manual seeding, from -7°C the ETG-exposed group, 89 out of 101 mouse zygotes (88%) to -33°C at -0.3°C/min, from -33°C to -150°C at -50°C/min; the cleaved after 24 h of culture, while in the control group 85 embryos were then plunged into liquid nitrogen.
cells out of 101 cleaved (84%). After a further 96 h, 78
For thawing, the straws were held in air for 15 s and then plunged embryos became expanded blastocysts in the exposed group into a water bath at 37°C for a few seconds until the ice melted. The (88%), and 65 in the control group (76%). The differences cryoprotectants were removed from the embryos in three steps: between the two groups (χ 2 test) were not statistically signi- Toxicity test on mouse zygotes exposed to 1.5 mol/l 1,2-propanediol (PROH), expressed as percentages of embryos ethylene glycol (ETG). The percentages of 2-cell embryos and originally frozen with ETG (n ϭ 207) or PROH (n ϭ 61). expanded blastocysts were recorded at 24 h and 120 h respectively following the moment of exposure. No statistically significant differences (χ 2 test) were observed between the two groups. 108 (57%) became expanded blastocysts. This value was significantly lower compared with the group of 133 unfrozen control embryos where 113 (85%) became expanded blastocleaved (82%), and 75 became expanded blastocysts (44%). In the control group (not frozen embryos), 85% of the zygotes cysts (χ 2 ; P Ͻ 0.01). Figure 5 shows the results of a separate experiment in which 4-cell stage embryos were frozen with (133/156) cleaved after 120 h and 85% (113/133) became expanded blastocysts. The difference in EBP between the two ETG or PROH. In total, 87 cells were frozen with ETG, 71 survived the thaw (82%), and 47 became expanded blastocysts groups was statistically significant (P Ͻ 0.01). When the zygotes were frozen with PROH, 92% survived after thawing (66%). In addition, 93 cells were frozen with PROH, 82 survived (88%), and 48 became expanded blastocysts (59%). (70/76), 96% cleaved (67/70), and 70% (47/67) became expanded blastocysts. The difference in SR between the ETG No significant differences (χ 2 test) were observed in SR and EBP between the two groups. and PROH frozen groups was statistically significant (χ 2 ; P Ͻ 0.01).
Blastocyst freezing 4-cell stage embryo freezing
The results of freezing young blastocysts (96 h after collection of zygotes) with either ETG or glycerol are shown in Figure 6 . The percentages of damaged blastomeres in 4-cell stage embryos frozen with ETG (n ϭ 207) and PROH (n ϭ 61) are
In total, 103 blastocysts were frozen with ETG, and 50 (49%) for blastocyst vitrification (Vanderzwalmen et al., 1998) , and no data are available regarding its use for human embryo cryopreservation with slow-freezing protocols. This suggests that preliminary larger studies evaluating the cryoprotective properties of ETG, by employing freezing-thawing conditions similar to those used for human embryos, are necessary. It was observed recently (Shaw et al., 1995) that previous studies comparing the cryoprotective properties of ETG and PROH in animal early embryos by slow cooling (Voelkel and Hu, 1992; Takagi et al., 1994a) , did not use thawing conditions which resemble those used in human embryo freezing with PROH (Lassalle et al., 1985) . Different freezing-thawing protocols were employed for blastocyst cryopreservation with ETG or glycerol in animals (Takagi et al., 1994b; Cocero et al., 1996; Sommerfeld and Niemann, 1999) and with glycerol survival of slow-cooled mouse early embryos was evaluated earlier (Shaw et al., 1995) by comparing different thawing conditions which closely resembled those used for freezing human embryos, the temperature in the straw being measured or too slowly (by keeping the straw in air for longer). Our results from freezing pronuclear stage and 4-cell stage re-expanded after 18-20 h of culture; 115 blastocysts were embryos differed somewhat from those reported earlier (Shaw frozen with glycerol and 75 (65%) re-expanded. The difference et al., 1995) . In our experience, ETG did not seem to be a between the two groups was statistically significant (χ 2 ; P good cryoprotectant for pronuclear stage embryos, but both Ͻ 0.05).
survival rate and expanded blastocyst rate improved when The percentages of expanded blastocysts obtained after 4-cell stage embryos were frozen, both with ETG and PROH. freezing mouse embryos at different stages of development Furthermore, compared with these earlier studies (Shaw et al., with 1.5 mol/l ETG are summarized in Table I . The higher 1995), a lower survival rate for 4-cell stage embryos was EBP was reached with 4-cell stage embryos.
observed with both cryoprotectants in our study, though this may be due to differences in genetic constitution between the Discussion two mouse strains used. Furthermore, Shaw and colleagues left the 4-cell stage embryos in the oviducts until 52-53 h after Ethylene glycol appears to have a low toxic effect on mouse embryos, confirming the results reported previously for other the injection of HCG; this represented a more physiological situation compared with our study, where the embryos were animal species (Ali and Shelton, 1993b; Donnay et al., 1998; Sommerfeld and Niemann, 1999) . The Van t'Hoff curve for removed from the oviduct at the pronuclear stage. Finally, interlaboratory variations in chemical and physical factors 1.5 mol/l ETG showed that a short time interval was necessary for the exposed zygotes to restore their initial volume after might be a further reason for these observed differences. Dimethlysulphoxide (DMSO), the classical cryoprotectant used shrinkage, and this observation suggested a rapid diffusion and a quick equilibration of ETG into the cell through the for 4-to 8-cell stage embryos, is more toxic than other cryoprotectants (Kasai et al., 1981; Ali and Shelton, 1993b) ; zona pellucida and the cellular membrane. On the other hand, the excessive shrinkage observed suggested the risk of an while its use extends the freezing procedure, because of a slow cooling phase until -80°C, it is less practical for multicellular intense osmotic stress by exposing the embryos to this ETG concentration.
embryo freezing. Thus, the present data concerning the survival rate of 4-cell stage embryos are quite interesting in relation to Although ETG is chemically closely related to 1,2-propanediol, only one report exists concerning its use in the human a potential use for ETG in the freezing of human embryos.
ETG has been largely used for blastocyst vitrification in of embryo viability caused by a longer period of in-vitro culture as a reason for lower embryo resistance to the freezing animals (Ali and Shelton, 1993b; Zhu et al., 1996; Sommerfeld and Niemann 1999) and humans (Vanderzwalmen et al., 1998) , was proposed.
In conclusion, ETG does not appear to be a good alternative but because of the previously reported better outcome of cryopreserved embryos frozen with a slow cooling procedure to the classical 1,2-propanediol and glycerol methods for freezing of mouse pronuclear stage embryos and blastocysts. compared with rapid and ultrarapid freezing ( Van den Abbeel et al., 1997; Sommerfeld and Niemann 1999) , we were more
The low toxicity observed, together with the good survival and expanded blastocyst rates obtained after freezing of mouse attracted by a slow-freezing protocol. The survival of mouse blastocysts before the moment of hatching frozen with ETG 4-cell stage embryos, may satisfy the real need in our centre for an alternative freezing protocol for 4-cell stage human observed in our study is not really satisfactory. Glycerol, the classical cryoprotectant used for blastocyst cryopreservation embryos. gave a significantly higher blastocyst survival rate (P Ͻ 0.05). Many studies have evaluated the cryoprotective properties ofwhile in another (Cocero et al., 1996b) with both cryoprotectants. In the final study (Sommerfeld and Devreker, F., Emiliani, S., Revelard, P. et al. (1999) Comparison of two Niemann, 1999) , a high hatching rate of bovine blastocysts elective transfer to reduce multiple pregnancy without impairing pregnancy (81%) frozen with ETG was observed. In the present study, rates. Hum. Reprod., 14, [83] [84] [85] [86] [87] [88] [89] significantly better results for blastocyst freezing were obtained Donnay, I., Auquer, P., Kaidi, S. et al. (1998) role in the interaction between the cytoplasm and the cryoproTheriogenology, 41, 310-315. tectant. The observed decline in blastocyst survival rate (92% Takagi, M., Sakonjiu, I. and Otoi, T. (1994b) Post-thaw viability of the inner and 88% for early embryos with PROH compared with 65% cell mass of in vitro matured/in vitro fertilized bovine embryos frozen in various cryoprotectants. Cryobiology, 31, 398-405. for blastocysts with glycerol) confirms previous data (Troup Troup, S.A., Matson, P.L., Critchlow, J.D. et al. (1990 ) Cryopreservation of et al., 1990 Nakayama et al., 1995) , where a low develophuman embryos at the pronucleate, early cleavage or expanded blastocyst mental, survival rate and no pregnancies were observed after 
